Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation
about
Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Discovery of BPR1K871, a quina ...... n vitro and in vivo evaluation
@en
Discovery of BPR1K871, a quina ...... vitro and in vivo evaluation.
@nl
type
label
Discovery of BPR1K871, a quina ...... n vitro and in vivo evaluation
@en
Discovery of BPR1K871, a quina ...... vitro and in vivo evaluation.
@nl
prefLabel
Discovery of BPR1K871, a quina ...... n vitro and in vivo evaluation
@en
Discovery of BPR1K871, a quina ...... vitro and in vivo evaluation.
@nl
P2093
P2860
P356
P1433
P1476
Discovery of BPR1K871, a quina ...... n vitro and in vivo evaluation
@en
P2093
An-Siou Li
Chen-Lung Huang
Ching-Chuan Kuo
Ching-Ping Chen
Chiung-Tong Chen
Chuan Shih
Chun-Hwa Chen
Chun-Wei Chang
Fu-Ming Kuo
Hui-Yi Shiao
P2860
P304
86239-86256
P356
10.18632/ONCOTARGET.13369
P407
P577
2016-11-15T00:00:00Z